Lannett Company (NYSE:LCI) announces that it has completed extracting the core software supporting the operations of Kremers Urban Pharmaceuticals, which it acquired in November 2015 for $1.23B.
The prototypal processor “Urban Material Map” was developed in the framework of the ASI-funded project “Sviluppo di Prodotti Iperspettrali Prototipali Evoluti” whose main objective was the prototyping ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback